津药药业 (600488.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.2x

Market Cap

CNY 5.64B

MomentumView details →

1D Return

−6.17%

YTD Return

+25.92%

RSI (14)

42.3

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

13.2x

Market Cap

CNY 5.64B

RSI (14)

42.3

MomentumView details →

1D Return

−6.17%

YTD Return

+25.92%

ProfitabilityView details →

Gross Margin

41.18%

Net Margin

0.97%

EBITDA Margin

17.78%

ROE (TTM)

0.87%

ROA (TTM)

0.47%

Asset Turnover

0.48x

GrowthView details →

Revenue YoY

−12.97%

EPS YoY

−79.87%

FCF YoY

−80.96%

Revenue CAGR 3Y

−7.62%

EPS CAGR 3Y

+26.64%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.21x

Current Ratio

2.08x

Quick Ratio

1.47x

Div Yield

1.01%

Div Rate

CNY 0.05

Div Growth 1Y

−46.94%

Financials snapshotView financials →

Revenue (TTM)

2.73B

Net Income (TTM)

26.41M

Op. CF (TTM)

135.63M

Latest newsMore news →

Jinyao Pharmaceutical announced its 2026 first-half results: net profit attributable to shareholders was 43.1735 million yuan, down 12.43% year-on-year.11d ago

Tianjin Pharmaceutical's subsidiary Jin Yao Heping (Tianjin) Pharmaceutical Co., Ltd. received a drug registration certificate from the Myanmar Ministry of Health for its pediatric compound amino acid injection (18AA-I), allowing production and sale in Myanmar.19d ago

Similar companies

Amneal Pharmaceuticals, Inc.AMRX 华纳药厂688799.SH 人民同泰600829.SH 圣诺生物688117.SH 辰欣药业603367.SH Shenzhen Hepalink Pharmaceutical Group Co., Ltd.09989.HK Find similar companies →

Latest newsMore news →

Jinyao Pharmaceutical announced its 2026 first-half results: net profit attributable to shareholders was 43.1735 million yuan, down 12.43% year-on-year.11d ago Tianjin Pharmaceutical's subsidiary Jin Yao Heping (Tianjin) Pharmaceutical Co., Ltd. received a drug registration certificate from the Myanmar Ministry of Health for its pediatric compound amino acid injection (18AA-I), allowing production and sale in Myanmar.19d ago